Ignite Creation Date:
2025-12-24 @ 4:50 PM
Ignite Modification Date:
2025-12-27 @ 9:32 AM
Study NCT ID:
NCT04661150
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-21
First Post:
2020-12-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-12
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-07-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-03
First Submit QC Date:
None
Study First Post Date:
2020-12-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-03-11
Results First Submit QC Date:
None
Results First Post Date:
2024-10-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-16
Last Update Post Date:
2025-10-21
Last Update Post Date Type:
ESTIMATED